Photodynamic therapy for melanoma precursor lesion Lentigo maligna using 5-aminolevulinic acid nanoemulsion as a light sensitizing cream

• Conditions: entigo maligna; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2015-004111-20-FI
• Lead Sponsor: Janne Räsänen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-09-29
• Last Update Posted: 18 January 2016

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients with non-invasiveLentigo maligna located in the skin of face, neck or upper body region.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 5
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

Biopsy shows invasive melanoma inside Lentigo maligna lesion prior treatment. Porfyria or solar dermatitis. Allergy for
photosensitizers used in study. Pregnant or breastfeeding patients.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified